There have been 44 initial public offerings (IPOs) listed on the US stock markets in 2024 thus far, many of which continue to trade at a premium to their initial offering price, demonstrating the strength and buoyancy of...more
4/16/2024
/ Acquisitions ,
Capital Markets ,
Disclosure Requirements ,
Dual Track Process ,
Initial Public Offering (IPO) ,
Interest Rates ,
Life Sciences ,
Mergers ,
Price Inflation ,
Private Equity ,
Securities and Exchange Commission (SEC) ,
Shareholders ,
Stock Prices ,
Valuation ,
Wages
In this dynamic global landscape, investors have always been required to make savvy, smart choices. This requires navigating through the intricate web of bilateral treaty protection, exploring the vital role these agreements...more
12/20/2023
/ Acquisitions ,
Bilateral Investment Treaties ,
Buyers ,
Carve Out Provisions ,
Cross-Border Transactions ,
Energy Sector ,
EU ,
Financial Regulatory Reform ,
Foreign Investment ,
Foreign Subsidiaries ,
Foreign Subsidies ,
Healthcare ,
Hedging ,
International Trade ,
Investment ,
Investors ,
Jurisdiction ,
Life Sciences ,
Mergers ,
Regulatory Agenda ,
Sellers ,
Sports ,
Technology Sector ,
UK
Please join McDermott for our highly anticipated Life Sciences Dealmaking Symposium! Now in its 12th year, the Symposium offers a unique platform for education, insight sharing, purposeful networking and strategic...more
10/23/2023
/ Acquisitions ,
Artificial Intelligence ,
Asset Valuations ,
Capital Markets ,
Capital Raising ,
Carve Out Provisions ,
Collaboration ,
Cross-Border Transactions ,
Events ,
Health Care Providers ,
Health Technology ,
Initial Public Offering (IPO) ,
Investors ,
IP License ,
IP Portfolio ,
Life Sciences ,
Mergers ,
Pharmaceutical Industry ,
Private Equity Firms ,
Publicly-Traded Companies ,
Special Purpose Acquisition Companies (SPACs)